Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,683 | 11,357 | 14,512 | 16,800 | 19,946 |
| Receivables | 494 | 612 | 294 | 574 | 481 |
| Inventories | 562 | 540 | 240 | 1,608 | 1,397 |
| TOTAL | $11,769 | $13,403 | $16,256 | $19,553 | $22,710 |
| Non-Current Assets | |||||
| PPE Net | 48 | 59 | 65 | 71 | 75 |
| Intangibles | 8,227 | 8,108 | 8,272 | 8,416 | 8,476 |
| Other Non-Current Assets | 707 | 814 | 418 | 422 | 373 |
| TOTAL | $8,982 | $8,981 | $8,755 | $8,909 | $8,924 |
| Total Assets | $20,751 | $22,384 | $25,011 | $28,462 | $31,634 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,200 | 2,668 | 2,791 | 2,280 | 2,146 |
| Other current liabilities | 1,451 | 620 | 887 | 753 | 566 |
| TOTAL | $7,022 | $5,623 | $5,596 | $5,372 | $5,616 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 74 | 74 | 249 | N/A | N/A |
| Other Non-Current Liabilities | 16,535 | 20,081 | 17,250 | 15,680 | 16,508 |
| TOTAL | $16,757 | $20,321 | $17,508 | $15,680 | $16,508 |
| Total Liabilities | $23,779 | $25,944 | $23,104 | $21,052 | $22,124 |
| Shareholders' Equity | |||||
| Common Shares | 223,140 | 222,335 | 222,335 | N/A | 222,335 |
| Retained earnings | -315,977 | -315,427 | -309,781 | N/A | -302,134 |
| Other shareholders' equity | 89,809 | 89,532 | 89,353 | 7,410 | 89,309 |
| TOTAL | $-3,028 | $-3,560 | $1,907 | $7,410 | $9,510 |
| Total Liabilities And Equity | $20,751 | $22,384 | $25,011 | $28,462 | $31,634 |